Form 4 for CRBP Corbus Pharmaceuticals Holdings, Inc.
Accepted 2022-05-16 00:00:00 ET · period of report 2022-05-16 · accession 0001209191-22-029030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-16 | 2022-05-16 | CRBP | Cohen Yuval | CEO, Dir | P - Purchase | $0.25 | +10.5K | 94.4K | +13% | +$2,625 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-16 | P | A | 10,500 | $0.25 | 94,430 | D | — | — |